Lieverse, RIY ;
Van Limbergen, EJ ;
Oberije, CJG...
Lieverse , RIY , Van Limbergen , EJ , Oberije , CJG , Troost , EGC , Hadrup , SR , Dingemans , AMA , Hendriks , LEL , Eckert , F , Hiley , C , Dooms , C , Lievens , Y , de Jong , M , Bussink , J , Geets , X , Valentini , V , Elia , G , Neri , D , Billiet , C , Abdollahi , A , Du Pasquier , D , Boisselier , P , Yaromina , A , De Ruysscher , D , Dubois , LJ & Lambin , P 2020 , ' Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial ' , BMC Cancer , vol. 20 , no. 1 . https://doi.org/10.1186/s12885-020-07055-1.
,
2020
